Ch.J. Vecht

2.7k total citations
37 papers, 1.8k citations indexed

About

Ch.J. Vecht is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ch.J. Vecht has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Neurology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ch.J. Vecht's work include Glioma Diagnosis and Treatment (14 papers), Brain Metastases and Treatment (9 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Ch.J. Vecht is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Brain Metastases and Treatment (9 papers) and Autoimmune Neurological Disorders and Treatments (6 papers). Ch.J. Vecht collaborates with scholars based in Netherlands, United States and Belgium. Ch.J. Vecht's co-authors include Martin J. van den Bent, Wim L.J. van Putten, Hein G. de Bruin, C.S.M. Straathof, A. Hovestadt, Diederik W.J. Dippel, Hans van Vliet, H Verbiest, J. Moll and Peter J. Koehler and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ch.J. Vecht

36 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ch.J. Vecht Netherlands 19 766 759 518 473 348 37 1.8k
G. Trasimeni Italy 20 624 0.8× 539 0.7× 389 0.8× 226 0.5× 260 0.7× 66 1.6k
Susanne Koeppen Germany 18 375 0.5× 794 1.0× 385 0.7× 307 0.6× 178 0.5× 33 1.6k
H. S. Greenberg United States 23 380 0.5× 524 0.7× 490 0.9× 210 0.4× 177 0.5× 43 1.6k
Takanori Inamura Japan 24 386 0.5× 619 0.8× 753 1.5× 262 0.6× 299 0.9× 91 2.5k
Yeon‐Lim Suh South Korea 26 466 0.6× 745 1.0× 509 1.0× 129 0.3× 302 0.9× 94 1.9k
Mila Blaivas United States 27 331 0.4× 418 0.6× 468 0.9× 197 0.4× 365 1.0× 75 2.1k
Jun‐ichi Kuratsu Japan 26 344 0.4× 822 1.1× 723 1.4× 328 0.7× 436 1.3× 120 2.4k
N C Yue United States 11 707 0.9× 867 1.1× 345 0.7× 229 0.5× 162 0.5× 13 1.8k
Steven R. Isaacson United States 18 613 0.8× 725 1.0× 318 0.6× 320 0.7× 182 0.5× 45 1.4k
Hasen Xue United States 23 357 0.5× 947 1.2× 488 0.9× 157 0.3× 574 1.6× 50 2.4k

Countries citing papers authored by Ch.J. Vecht

Since Specialization
Citations

This map shows the geographic impact of Ch.J. Vecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch.J. Vecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch.J. Vecht more than expected).

Fields of papers citing papers by Ch.J. Vecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch.J. Vecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch.J. Vecht. The network helps show where Ch.J. Vecht may publish in the future.

Co-authorship network of co-authors of Ch.J. Vecht

This figure shows the co-authorship network connecting the top 25 collaborators of Ch.J. Vecht. A scholar is included among the top collaborators of Ch.J. Vecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch.J. Vecht. Ch.J. Vecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brouwer, Rolf E., et al.. (2007). Leptomeningeal disease in chronic lymphocytic leukemia. Clinical Neurology and Neurosurgery. 109(10). 896–901. 22 indexed citations
2.
Jongen, Joost L.M., et al.. (2005). Intrathecal injection of GDNF and BDNF induces immediate early gene expression in rat spinal dorsal horn. Experimental Neurology. 194(1). 255–266. 29 indexed citations
3.
Boogerd, Willem, Martin J. van den Bent, Peter J. Koehler, et al.. (2004). The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. European Journal of Cancer. 40(18). 2726–2733. 210 indexed citations
4.
Wagner, G, Erik B. Wilms, Cees A. van Donselaar, & Ch.J. Vecht. (2003). Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure. 12(8). 585–586. 91 indexed citations
5.
Vecht, Ch.J., Martin J. van den Bent, & Denis Lacombe. (2002). EORTC Brain Tumor Group. European Journal of Cancer. 38. 35–38. 18 indexed citations
6.
Bent, Martin J. van den, et al.. (1999). Phase II Study of Weekly Dose-intensified Cisplatin Chemotherapy with Oral Etoposide in Recurrent Glioma. Journal of Neuro-Oncology. 44(1). 59–64. 9 indexed citations
7.
Straathof, C.S.M., et al.. (1999). The Accumulation of Topotecan in 9L Glioma and in Brain Parenchyma with and without Dexamethasone Administration. Journal of Neuro-Oncology. 42(2). 117–122. 20 indexed citations
8.
Straathof, C.S.M., Hein G. de Bruin, Diederik W.J. Dippel, & Ch.J. Vecht. (1999). The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. Journal of Neurology. 246(9). 810–814. 172 indexed citations
9.
Bent, Martin J. van den, Jan H.M. Schellens, Ch.J. Vecht, et al.. (1998). Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas. European Journal of Cancer. 34(10). 1570–1574. 9 indexed citations
10.
Planting, A.S.T., S.H. Goey, Jan H.M. Schellens, et al.. (1996). Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma. European Journal of Cancer. 32(11). 2026–2028. 7 indexed citations
11.
Hilkens, P.H.E., Jaap Verweij, G. Stoter, et al.. (1996). Peripheral neurotoxicity induced by docetaxel. Neurology. 46(1). 104–108. 87 indexed citations
12.
Hilkens, P.H.E., M.E.L. van der Burg, J. Moll, et al.. (1995). Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration. European Journal of Cancer. 31(5). 678–681. 18 indexed citations
13.
Hilkens, P.H.E., M.E.L. van der Burg, J. Moll, et al.. (1995). Effect of an ACTH(4–9) analogue on cisplatin neuropathy of longstanding duration: a phase II study. Clinical Neurology and Neurosurgery. 97(2). 139–141. 3 indexed citations
14.
Moll, J., J. C. Antoine, H. Robert Brashear, et al.. (1995). Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology. 45(10). 1937–1941. 76 indexed citations
15.
Moll, J. & Ch.J. Vecht. (1995). Immune diagnosis of paraneoplastic neurological disease. Clinical Neurology and Neurosurgery. 97(1). 71–81. 10 indexed citations
16.
Vecht, Ch.J.. (1995). Brain tumor invasiveness. Clinical Neurology and Neurosurgery. 97(3). 283–283. 3 indexed citations
17.
Hilkens, P.H.E., André Planting, M.E.L. van der Burg, et al.. (1994). Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule. European Journal of Neurology. 1(1). 45–50. 11 indexed citations
18.
Henzen‐Logmans, S.C., et al.. (1990). Anti-neuronal antibodies in paraneoplastic neurological disorders with small-cell lung carcinoma. Clinical Neurology and Neurosurgery. 92(3). 223–228. 5 indexed citations
19.
20.
Vecht, Ch.J., et al.. (1976). On the nature of brain stem disorders in severe head injured patients. Acta Neurochirurgica. 34(1-4). 11–21. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Trasimeni Breakdown of academic impact, for papers by Susanne Koeppen Breakdown of academic impact, for papers by H. S. Greenberg Breakdown of academic impact, for papers by Takanori Inamura Breakdown of academic impact, for papers by Yeon‐Lim Suh Breakdown of academic impact, for papers by Mila Blaivas Breakdown of academic impact, for papers by Jun‐ichi Kuratsu Breakdown of academic impact, for papers by N C Yue Breakdown of academic impact, for papers by Steven R. Isaacson Breakdown of academic impact, for papers by Hasen Xue
Rankless by CCL
2026